Tafamidis Treatment Decreases 99mTc-Pyrophosphate Uptake in Patients With Hereditary Ala97Ser Transthyretin Amyloid Cardiomyopathy-Reference-Cited by-同舟云学术

Tafamidis Treatment Decreases 99mTc-Pyrophosphate Uptake in Patients With Hereditary Ala97Ser Transthyretin Amyloid Cardiomyopathy

Published:2023-06 Issue:6 Volume:16 Page:866-867
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Yu An-Li^ORCID,Chen Yi-Chieh,Tsai Cheng-Hsuan^ORCID,Chao Chi-Chao,Su Mao-Yuan,Juang Jimmy Jyh-Ming,Lee Ming-Jen,Hsieh Sung-Tsang,Cheng Mei-Fang,Lin Yen-Hung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference5 articles.

1. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis;Castano;JAMA Cardiol,2016

2. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis;Gillmore;Circulation,2016

3. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy;Maurer;N Engl J Med,2018

4. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses;Bokhari;Circ Cardiovasc Imaging,2013

5. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis;Castano;J Nucl Cardiol,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diflunisal versus tafamidis on neuropathy and cardiomyopathy in hereditary transthyretin amyloidosis;Annals of Clinical and Translational Neurology;2024-08-02

2. Single center analysis of cardiac amyloidosis using 99mTc-HMDP imaging for diagnosis and evaluation after tafamidis treatment;2024-06-07

3. Letter to the editor concerning “Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?”;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-24

4. Performance of 99mTc-PYP scintigraphy in the diagnosis of hereditary transthyretin cardiac amyloidosis;Annals of Nuclear Medicine;2024-01-22

5. Use of Technetium‐99m‐Pyrophosphate Single‐Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy;Journal of the American Heart Association;2024-01-16